ANVISA decides that a patent application related to pharmaceutical use of cannabinoids is not to be deemed as against public health
On November 17th, 2020, ANVISA’s Board of Directors (BoD) unanimously granted an administrative appeal for reassessment of prior consent of a patent … ANVISA decides that a patent application related to pharmaceutical use of cannabinoids is not to be deemed as against public health